Induction AA rolls out new services nationwide

RNS Number : 5725U
Induction Healthcare Group PLC
06 December 2021
 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Induction Attend Anywhere rolls out new services nationwide

 

Induction Healthcare (AIM: INHC), a leading healthcare technology company that helps to digitally transform hospitals, announces that its remote consultation service, Induction Attend Anywhere, has launched a key new healthcare function. The platform, which has been rolled out across the UK, now also supports clinical group consultations, where one-to-one consultations take place within a group setting of patients with similar clinical conditions.

 

The pandemic, and related restrictions have impacted many group services including addiction and mental health therapy provision. To date clinicians offering digital group consultations have had to rely on non-clinical business conferencing facilities to maintain some continuity, but these can come with privacy and usability limitations.

 

Facing a backlog and an estimated 10 million people who may need new or additional mental health support over the next three to five years (according to the NHS Confederation), clinicians require a flexible care model which enables remote group consultations at scale and within a clinically safe setting.

 

Co-created with NHS providers, the Induction Attend Anywhere clinical group consultations function has been designed to virtually mirror standard clinical and patient workflow for optimum integration. A distinctive feature is that there is a single-entry link for each clinical group consultation Waiting Area, avoiding production of multi-patient links and helping to safeguard clinician and patient confidentiality.

 

The new function leverages next generation patient entry and includes "in call" features and controls that reduce clinical risk and prioritise privacy and security. For example, only the service providers can see callers' names and they have full control to admit, deny or remove individual participants.

 

Through Induction Attend Anywhere patients can be confident that the platform is separate from their business or personal accounts, and that their information is anonymised for all others participating in the remote clinical consultation. This is particularly important for clinical group consultations where confidentiality is paramount. Key features here ensure no digital footprint is the left by patients and that the consultation room cannot be re-joined to view any chat data.

 

The development of a clinical group consultations function offers immediate support to the 300,000 health professionals who already use Induction Attend Anywhere. More broadly, it provides another important tool to enable community-based healthcare, a key aim of the NHS Long Term Plan.

 

James Balmain, CEO of Induction Healthcare said: "We are delighted to share the expansion of our Induction Attend Anywhere platform, which enables the NHS to integrate remote clinical group consultations within a secure and private setting. This bespoke function will support the NHS to scale-up crucial services like counselling to some of the hardest to reach patients. It will help address the current backlog while transforming healthcare for the longer-term."

 

 

ENQUIRIES

 

Induction

James Balmain, Chief Executive Officer

Dr Hugo Stephenson, Group Executive Director

Via Walbrook PR Ltd: induction@walbrookpr.com



Singer Capital Markets (Nominated Adviser and Broker)

+44 (0) 20 7496 3000

Philip Davies / Kailey Aliyar




Walbrook PR Ltd 

induction@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

About Induction -   www.inductionhealthcare.com

 

Induction (AIM: INHC) is a leading virtual care platform driving digital transformation of healthcare systems worldwide. Induction solutions enhance the investments hospitals have made and lay the foundation for their future. Our products can enable information sharing between busy doctors, alleviate operational burdens on hospitals or put patients in better control of their care, all while ensuring the highest standards of clinical safety and information security. We unchain staff and patients from the limitations of paper-based and desktop systems, creating substantial time and cost efficiencies.

 

More than 225,000 hospital doctors across multiple territories, including the UK, Ireland, Australia and South Africa, as well as a rapidly growing number of more than 300,000 UK patients, choose Induction solutions.

 

Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.

 

Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.

 

Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals.

 

Induction Attend Anywhere   is the UK market leader in secondary care video consultations. It helps hospitals, health systems and other customers offer video consultations to patients and service users as a normal part of day-to-day clinical activity. Our vision is for video consultations to improve lives and help address social, access, equity and sustainability challenges by allowing healthcare providers to determine how and when they see a patient based on each individual case: in-person, via video or on the telephone.

 

Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.

 

 

About RNS Reach announcements

 

RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABUBDDDXGDGBX
UK 100

Latest directors dealings